Browse > Article
http://dx.doi.org/10.5352/JLS.2007.17.10.1361

A Protein Kinase-A Inhibitor, KT5720, Suppressed Cytopathic Effect Caused by Vesicular Stomatitis Virus  

Kim, Young-Sook (Department of Oriental Medical Food and Nutrition, Asia University)
Publication Information
Journal of Life Science / v.17, no.10, 2007 , pp. 1361-1367 More about this Journal
Abstract
I investigated the effect of KT5720, an inhibitor of protein kinase A, on the vesicular stomatitis virus (VSV) infection in BHK-21cell cultures. The virus inducted cytopathic effect (CPE) was almost completely suppressed by KT5720 at 5uM. The inhibitor, however, did not affect replication of the virus nor the synthesis of viral macromolecules. KT5720, did not block the cytoskeletal disruption, while the cell rounding was suppressed. And, the KT5720-sensitive function may be involved in developing the VSV-induced CPE, but not essential for the virus replications.
Keywords
Vesicular stomatitis virus (VSV); KT5720; cytopathic effect (CPE);
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ono, K., M. E. Dubois-Dalcq, M. Schubert and R. A. Lazzarini. 1987. A mutated membrane protein of vesicular stomatitis virus has an abnormal distribution within the infected cell and causes defective budding. J. Virol. 61, 1332-1341.
2 Sun, Y. W., K. Suryanarayana, P. Jusjtice, D. Robinson and R. R. Wagner. 1994. Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus. J. Virol. 68, 7386-7396.
3 Tsukita, S., K. Oishi, N. Sato, J. Sagara, A. Kawai and S. Tsukita. 1994. ERM Family Members as Molecular Linkers between the Cell Surface Glycoprotdn CD44 and Actin-based Cytoskeletons. J. Cell Biol. 126, 391-401.   DOI   ScienceOn
4 Weck, P. K., A. R. Caeeol, D. M. Shattuck and R. R. Wagner. 1976. Use of UV Irradiation to Identify the Genetic Information of Vesicular Stomatitis Virus Responsible for Shutting Off Cellular RNA Synthesis. J. Virol. 30, 746-753.
5 Willson, T. and J. Lenard. 1981. Interaction of wild-type and mutant M protein of vesicular stomatitis virus with nucleocapsids in vitro. Biochemistry 20, 1349-1354.   DOI   ScienceOn
6 Morimoto, K., Y. J. Ni and A. Kawai. 1992. Syncytium formation is induced in the murine neuroblastoma cell cultures which produce pathogenic type G proteins of the rabies virus. Virology 189, 203-216.   DOI   ScienceOn
7 Naito, S. and S. Matsumoto. 1978. Identification of cellular actin within the rabies virus. Virology 91, 151-163.   DOI   ScienceOn
8 Nakanishi, S., K. Yamada, H. Kase, S. Nakamura and Y. Nonomura. K-252a, a novel microbial product, inhibits smooth muscle myosin light chain kinase J. Biol. Chem. 263, 6215-6219.
9 Nakanishi, S., K. Yamada, K. Iwahashi, K. Kuroda and H. Kase. 1990. KT5926, a Potent and Selective Inhibitor of Myosin Light Chain Kinase. Molec. Phamacol. 37, 482-488.
10 Newcomb, W. W. and J. C. Brown. 1981. Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions. J. Virol. 39, 295-299.
11 Rutter, G. and K. Mannweiler. 1977. Alterations of Actin-Containing Structures in BHK21 Cells Infected with Newcastle Disease Virus and Vesicular Stomatitis Virus. J. Gen. Virol. 37, 233-242.   DOI   ScienceOn
12 Sagara, J. and A. Kawai. 1992. Identification of heat shock protein 70 in the rabies virion. Virology 190, 845-848.   DOI   ScienceOn
13 Kim, Y. S. and A. Kawai. 1998. Studies on the AntiviralMechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of Vesicular stomatitis virus. Biol. Pharm. Bull. 21, 498-505.   DOI   ScienceOn
14 Sagra, J., S. Tsukita, S. Yonemura, S. Tsukita and A. Kawai. 1995. Cellular actin-binding ezrin-radixin-moesin (ERM) family proteins are incorporated into the rabies virions and closely associated with viral envelope proteins in the cell. Virology 206, 485-494.   DOI   ScienceOn
15 Simon, K. O., P. A. Whiitaker-Dowling, J. S. Youngner and C. C. Widnell. 1990. Cited by other Osatomi and Sumiyoshi, Complete Nucleotide Sequence of Dengue Type 3 Virus Genome. Virology 177, 289-305.   DOI   ScienceOn
16 Kase, H., K. Iwahashi, S. Nakanisji, Y. Matsuda, K. Yamada, M. Takahashi, C. Murakata, A. Sato and M. Kaneko. 1987. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Comm. 142, 436-440.   DOI   ScienceOn
17 Kim, Y. S., J. Sagara and A. Kawai. 1995. Studies on the Antiviral Activity of protein kinase inhibitors against the replication of Vesicular stomatitis virus. Biol. Pharm. Bull. 18, 895-899.   DOI   ScienceOn
18 Kurilla, M. G., H. Piwnica-Worms and J. D. Keene. 1982. Rapid and Transient Localization of the Leader RNA of Vesicular Stomatitis Virus in the Nuclei of Infected Cells. Proc. Natl. Acid. Sci. USA 79, 5240-5244.   DOI
19 Laemmli, U. K. 1970. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature London 227, 680-685.   DOI   ScienceOn
20 Levine, B., Q. Huang, J. T. Isaacs, J. C. Reed, D. E. Griffin and J. M. Hardwick. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361, 739-742.   DOI   ScienceOn
21 Blondel, D., G. G. Harmison and M. Schubert. 1990. Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J. Virol. 64, 1716-1725.
22 McGowan, J. J., S. U. Emerson and R. R. Wagner. 1982. The plus-strand leader RNA of VSV inhibits DNA-dependent transcription of adenovirus and SV40 genes in a soluble whole-cell extract. Cell 28, 325-333.   DOI   ScienceOn
23 Melki, R., Y. Gardina and D. Blondel. 1994. Interaction between tubulin and the viral matrix protein of vesicular stomatitis virus: possible implications in the viral cytopathic effect. Virology 202, 339-347.   DOI   ScienceOn
24 Black, B. L. and D. Lyles. 1992. Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J. Virol. 66, 4058-4064.
25 Carroll, A. R. and R. R. Wagner. 1979. Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J. Virol. 29, 134-142.
26 Clinton, G. M., S. P. Little, F. S. Hagen and A. S. Huang. 1978. The matrix (M) protein of vesicular stomatitis virus regulates transcription. Cell 15, 1455-1462.   DOI   ScienceOn
27 Chong, L. D. and J. K. Rose. 1993. Membrane association of functional vesicular stomatitis virus matrix protein in vivo. J. Virol. 67, 407-414.
28 Grinnell, B. W. and R. R. Wagner. 1983. Comparative inhibition of cellular transcription by vesicular stomatitis virus serotypes New Jersey and Indiana: role of each viral leader RNA. J. Virol. 48, 88-101.
29 Gross-Bellard, M., P. Oudet and P. Chambon. 1973. Isolation of High-Molecular-Weight DNA from Mammalian Cells. J. Biochem. 36, 32-38.
30 Honda, Y., A. Kawai and J. Matsumoto. 1984. Comparative Studies of Rabies and Sindbis Virus Replication in Human Neuroblastoma (SYM-I) Cells that Can Produce Interferon J. Gen. Virol. 65, 1645-1653.   DOI   ScienceOn
31 Kaptur, P. E., R. B. Rhodes and D. S. Lyles. 1991. Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids. J. Virol. 65, 1057-1065.
32 Kawai, A. 1977. Transcriptase Activity Associated with Rabies Virion. J. Virol. 24, 826-835.